These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 8838417)

  • 1. Synthetic peptides from P. falciparum sexual stage 25-kDa protein induce antibodies that react with the native protein: the role of IL-2 and conformational structure on immunogenicity of Pfs25.
    Quakyi IA; Miller LH; Good MF; Ahlers JD; Isaacs SN; Nunberg JH; Houghten RA; Keister DB; Coligan JE; Moss B
    Pept Res; 1995; 8(6):335-44. PubMed ID: 8838417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tandem use of PCR and synthetic peptides to map helper T-cell epitopes on 27-kDa sexual stage antigen of Plasmodium falciparum.
    Koski GK; Ploton IN; Viscidi R; Kumar N
    Pept Res; 1996; 9(3):127-35. PubMed ID: 8875592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthetic peptide immunogens eliciting antibodies to Plasmodium falciparum sporozoite and merozoite surface antigens in H-2b and H-2k mice.
    Rzepczyk CM; Csurhes PA; Lord R; Matile H
    J Immunol; 1990 Oct; 145(8):2691-6. PubMed ID: 2212657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides reactive with a transmission-blocking monoclonal antibody against Plasmodium falciparum Pfs25: 2000-fold affinity increase by PEPSCAN-based amino acid substitutions.
    van Amerongen A; Beckers PJ; Plasman HH; Schaaper WM; Sauerwein RW; Meuwissen JH; Meloen RH
    Pept Res; 1992; 5(5):269-74. PubMed ID: 1280492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1.
    James S; Moehle K; Renard A; Mueller MS; Vogel D; Zurbriggen R; Pluschke G; Robinson JA
    Chembiochem; 2006 Dec; 7(12):1943-50. PubMed ID: 17068840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
    Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
    Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.
    Chang SP; Gibson HL; Lee-Ng CT; Barr PJ; Hui GS
    J Immunol; 1992 Jul; 149(2):548-55. PubMed ID: 1624802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.
    Udhayakumar V; Anyona D; Kariuki S; Shi YP; Bloland PB; Branch OH; Weiss W; Nahlen BL; Kaslow DC; Lal AA
    J Immunol; 1995 Jun; 154(11):6022-30. PubMed ID: 7538540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
    Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
    Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and mechanism of a transmission blocking vaccine candidate protein Pfs25 from P. falciparum: a molecular modeling and docking study.
    Sharma B
    In Silico Biol; 2008; 8(3-4):193-206. PubMed ID: 19032156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the T cell response to two allelic forms of a malarial vaccine candidate protein.
    Rzepczyk CM; Csurhes PA; Saul AJ; Jones GL; Dyer S; Chee D; Goss N; Irving DO
    J Immunol; 1992 Feb; 148(4):1197-204. PubMed ID: 1371134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of antibodies against the Plasmodium falciparum p126 antigen in non-responder H-2b and partial-responder H-2d mice using synthetic peptides.
    Gilardeau Truffinet M; Bossus M; Camus D; Delplace P; Mazingue C; Diesis E; Tartar A; Moreau S; Gras-Masse H; Banic DM
    Pept Res; 1996; 9(2):61-70. PubMed ID: 8738980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of the C-terminal 19-kDa fragment of the Plasmodium falciparum merozoite surface protein 1 (MSP1), YMSP1(19) expressed in S. cerevisiae.
    Hui GS; Gosnell WL; Case SE; Hashiro C; Nikaido C; Hashimoto A; Kaslow DC
    J Immunol; 1994 Sep; 153(6):2544-53. PubMed ID: 8077664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide mapping of conformational epitopes in a human malarial parasite heat shock protein.
    Richman SJ; Vedvick TS; Reese RT
    J Immunol; 1989 Jul; 143(1):285-92. PubMed ID: 2471738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.
    Quakyi IA; Carter R; Rener J; Kumar N; Good MF; Miller LH
    J Immunol; 1987 Dec; 139(12):4213-7. PubMed ID: 2447164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Universal" T helper cell determinants enhance immunogenicity of a Plasmodium falciparum merozoite surface antigen peptide.
    Kumar A; Arora R; Kaur P; Chauhan VS; Sharma P
    J Immunol; 1992 Mar; 148(5):1499-505. PubMed ID: 1371529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
    Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
    J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of synthetic carriers and adjuvants for increasing the immunogenicity of a synthetic peptide from the CS-protein of Plasmodium falciparum].
    Ivanov BB; Meshcheriakova EA; Andronova TM; Ivanov VT
    Bioorg Khim; 1991 Jun; 17(6):732-46. PubMed ID: 1723268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.